Pioglitazone
Product Images NDC 53002-2755

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 53002-2755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of the active ingredient pioglitazone hydrochloride, showing its molecular framework including aromatic rings, a thiazolidinedione ring, and hydrochloride association.*

FDA Label Image

Figure 1 (Image 2)

A line graph depicting mean values over weeks for different treatment groups: placebo, 15 mg, 30 mg, and 45 mg doses. The horizontal axis represents weeks, ranging from 0 to 26, while the vertical axis shows the mean values. The graph includes a legend identifying each group by distinct color and marker style.*

FDA Label Image

Label Image (Lbl530022755)

Pioglitazone HCL 15 mg tablet packaging label from RPK Pharmaceuticals, Inc., containing 30 tablets. The label indicates the medication is to be taken as one tablet daily or as directed and includes typical prescription information fields such as patient name, prescription date, and prescriber details. The label also shows lot number, expiration date, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.